Identification |
Name: | Butanediamide,N4-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-,(2S,3R)- |
Synonyms: | Butanediamide,N4-[2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-,[2S-[N4(R*),2R*,3S*]]-; BB 2516; GI 5712; KB-R 8898; Marimastat; TA 2516 |
CAS: | 154039-60-8 |
Molecular Formula: | C15H29 N3 O5 |
Molecular Weight: | 0 |
InChI: | InChI=1/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | 1.14g/cm3 |
Refractive index: | 1.498 |
Biological Activity: | Broad spectrum inhibitor of matrix metalloprotease (MMP) (IC 50 values are 3, 5, 6, 9 and 13 nM for MMP-9, MMP-1, MMP-2, MMP-14 and MMP-7 respectively). In vivo inhibits peritoneal dissemination of human gastric cancer cells through inhibition of tumor angiogenesis. |
Flash Point: | °C |
Safety Data |
|
|